Therefore, we sought to determine whether the differential diagnosis of ocular adnexal RFH, ALH, and MALToma could be performed based on CD23/IgD immunostaining and clinicopathological manifestations. The gene discussed is FCER2; the disease is atypical lobular breast hyperplasia.